Functional remediation improves bipolar disorder functioning with no effects on brain-derived neurotrophic factor levels

被引:11
|
作者
del Mar Bonnin, Caterina [1 ]
Valls, Elia [1 ]
Rosa, Adriane R. [2 ]
Reinares, Maria [1 ]
Jimenez, Esther [1 ]
Sole, Brisa [1 ]
Montejo, Laura [1 ]
Meseguer, Ana [3 ]
Pacchiarotti, Isabella [1 ]
Colom, Francesc [4 ]
Martinez-Aran, Anabel [1 ]
Tomioka, Yoko [1 ]
Vieta, Eduard [1 ]
Torrent, Carla [1 ]
机构
[1] Univ Barcelona, Barcelona Bipolar & Depress Disorders Program, Hosp Clin Barcelona, Inst Neurosci,IDIBAPS,CIBERSAM, Catalonia, Spain
[2] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[3] Univ Barcelona, Neurosci Inst, Hosp Clin Barcelona, Barcelona Clin Schizophrenia Unit, Catalonia, Spain
[4] Hosp del Mar, IMIM Inst Hosp Mar Invest Med, Mental Hlth Grp, CIBERSAM, Barcelona, Catalonia, Spain
关键词
Bipolar disorder; Functional remediation; Psychoeducation; BDNF; Functioning; VAL66MET POLYMORPHISM; RATING-SCALE; SERUM-LEVELS; BDNF; SCHIZOPHRENIA; RELIABILITY; DEPRESSION; KETAMINE; VALIDITY; BURDEN;
D O I
10.1016/j.euroneuro.2019.04.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The main aim of this study is to evaluate the impact of functional remediation (FR) in serum brain derived neurotrophic factor (BDNF) levels in euthymic adult patients with Bipolar Disorder (BD). A total of 128 participants were recruited at the Hospital Clinic of Barcelona. They were assessed at baseline and at the end of follow-up by the means of Hamilton Depression Scale (HAM-D), Young Mania Rating Scale (YMRS) and Functioning Assessment Short Test (FAST), as well as a clinical structured interview to collect clinical and demographic variables of interest. Blood samples were also collected to assess BDNF levels. After baseline assessment, patients received FR, Psychoeducation or treatment as usual (TAU). One hundred and two out of 126 participants finished the study distributed as follows: FR group (n = 39); Psychoeducation group (n = 47) and TAU group (n = 16). Longitudinal repeated-measures analyses addressing the treatment effect on BDNF levels showed non-significant differences between the three groups (Pillai's trace = 0.06; F-(2,F-97) = 0.28; p = 0.75), suggesting no interaction between treatment allocation and time on BDNF levels. The results of this study suggest that FR has no effect on peripheral BDNF levels in euthymic patients with BD, despite the improvement in psychosocial functioning. (C) 2019 Elsevier B.V. and ECNP. All rights reserved.
引用
收藏
页码:701 / 710
页数:10
相关论文
共 50 条
  • [1] Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder
    Videira Dias, Vasco
    Brissos, Sofia
    Frey, Benicio N.
    Andreazza, Ana Cristina
    Cardoso, Carlos
    Kapczinski, Flavio
    BIPOLAR DISORDERS, 2009, 11 (06) : 663 - 671
  • [2] Brain-derived neurotrophic factor (BDNF) and bipolar disorder
    Chiou Yu-Jie
    Huang Tiao-Lai
    PSYCHIATRY RESEARCH, 2019, 274 : 395 - 399
  • [3] Brain-derived neurotrophic factor in bipolar disorder: Associations with age at onset and illness duration
    Baykara, Burak
    Koc, Dogukan
    Resmi, Halil
    Akan, Pinar
    Tunca, Zeliha
    Ozerdem, Aysegul
    Ceylan, Deniz
    Yalcin, Neslihan Gurz
    Binici, Nagihan Cevher
    Guney, Sevay Alsen
    Mesman, Esther
    Hillegers, Manon H. J.
    Emiroglu, Neslihan Inal
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 108
  • [4] Increased plasma levels of brain-derived neurotrophic factor in patients with long-term bipolar disorder
    Barbosa, Izabela Guimaraes
    Huguet, Rodrigo Barreto
    Mendonca, Vanessa Amaral
    Neves, Fernando Silva
    Reis, Helton Jose
    Bauer, Moises Evandro
    Janka, Zoltan
    Palotas, Andras
    Teixeira, Antonio Lucio
    NEUROSCIENCE LETTERS, 2010, 475 (02) : 95 - 98
  • [5] Brain-derived Neurotrophic Factor (BDNF) and gray matter volume in bipolar disorder
    Poletti, S.
    Aggio, V.
    Hoogenboezem, T. A.
    Ambree, O.
    de Wit, H.
    Wijkhuijs, A. J. M.
    Locatelli, C.
    Colombo, C.
    Arolt, V.
    Drexhage, H. A.
    Benedetti, F.
    EUROPEAN PSYCHIATRY, 2017, 40 : 33 - 37
  • [6] Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder
    Gama, Clarissa Severino
    Andreazza, Ana Cristina
    Kunz, Mauricio
    Berk, Michael
    Silva Belmonte-de-Abreu, Paulo
    Kapczinski, Flavio
    NEUROSCIENCE LETTERS, 2007, 420 (01) : 45 - 48
  • [7] Decreased Brain-Derived Neurotrophic Factor in Older Adults with Bipolar Disorder
    Soares, Aline T.
    Andreazza, Ana C.
    Rej, Soham
    Rajji, Tarek K.
    Gildengers, Ariel G.
    Lafer, Beny
    Young, L. Trevor
    Mulsant, Benoit H.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2016, 24 (08) : 596 - 601
  • [8] Decreased peripheral brain-derived neurotrophic factor levels are not specific for bipolar disorder, major depressive disorder or schizophrenia
    Fernandes, B. S.
    Goncalves, C. A. S.
    BIPOLAR DISORDERS, 2011, 13 : 44 - 45
  • [9] Decreased plasma levels of brain-derived neurotrophic factor (BDNF) during mixed episodes of bipolar disorder
    Piccinni, Armando
    Veltri, Antonello
    Costanzo, Davide
    Vanelli, Federica
    Franceschini, Caterina
    Moroni, Ilenia
    Domenici, Luciano
    Origlia, Nicola
    Marazziti, Donatella
    Akiskal, Hagop Souren
    Dell'Osso, Liliana
    JOURNAL OF AFFECTIVE DISORDERS, 2015, 171 : 167 - 170
  • [10] Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder
    Tramontina, Juliana Fernandes
    Yates, Denise
    da Silva Magalhaes, Pedro Vieira
    Trentini, Clarissa
    Sant'Anna, Marcia Kauer
    Fries, Gabriel Rodrigo
    Bock, Hugo
    Saraiva-Pereira, Maria Luiza
    Kapczinski, Flavio
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2009, 31 (02) : 136 - 140